Advertisement

Atherosclerosis and Hyperlipoproteinaemia

Chapter
  • 279 Downloads
Part of the Treatment in Clinical Medicine book series (TC MEDICINE)

Abstract

Coronary heart disease (CHD) remains the leading cause of death in many countries. The fact that it may be declining in some areas (e.g. United States, Australia) allows no grounds for complacency. It is estimated that still more than 1.25 million Americans suffer a heart attack each year (Levy 1981), and in Scotland in 1977 the death rate from coronary disease was 800 per 100 000 population.

Keywords

Bile Acid Nicotinic Acid Familial Hypercholesterolaemia Lipid Research Clinic Clinic Coronary Primary Prevention Trial 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Committee of principal investigators (1978) A co-operative trial in the prevention of ischaemic heart disease using clofibrate. Br Heart J 40: 1069CrossRefGoogle Scholar
  2. Duffield RGM, Lewis B, Miller NE, Jameson CE, Brunt JNH, Colchester ACF (1983) Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. Lancet II:639–642CrossRefGoogle Scholar
  3. Editorial (1975) Lipids and ischaemic heart disease. Lancet II: 398Google Scholar
  4. Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 34PubMedCrossRefGoogle Scholar
  5. Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 94PubMedCrossRefGoogle Scholar
  6. Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 148PubMedCrossRefGoogle Scholar
  7. Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 215PubMedCrossRefGoogle Scholar
  8. Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 272Google Scholar
  9. Gordon T, Castelli WP, Mjortland MC, Kannel WB, Dawber TR (1977) Predicting coronary disease in middle-aged and older persons. The Framingham Study. JAMA 238: 497PubMedCrossRefGoogle Scholar
  10. Hjermann I, Velve Byre K, Holme I, Leren P (1981) Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet II: 1303–1310CrossRefGoogle Scholar
  11. Levy RI (1981) Lipoproteins, apoproteins and heart disease. Present status and future prospects. Clin Chem Acta 27: 653Google Scholar
  12. Miller GJ, Miller NE (1975) Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet I: 16CrossRefGoogle Scholar
  13. MRFIT Research Group (1982) Multiple risk factor intervention trial: risk factor changes and mortalitiy results. JAMA 248: 1465–1477CrossRefGoogle Scholar
  14. Murray RG, Tweddel A, Third JLHC, Hillis WS, Hutton I, Lorimer AR, Lawrie TDV (1975) Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia. Br Heart J 37: 1035Google Scholar
  15. Olsson AG, Carlson LA, Erikson U, Helmius G, Hemmingsson A, Ruhn G (1982) Regression of computer estimated femoral atherosclerosis after pronounced serum lipid lowering in patients with asymptomatic hyperlipidaemia. Lancet I: 1311CrossRefGoogle Scholar
  16. Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis. N Engl J Med 295: 420PubMedCrossRefGoogle Scholar
  17. The Lipid Research Clinics Coronary Primary Prevention Trial Results (1984) I. Reduction in incidence of coronary heart disease. JAMA 251: 351CrossRefGoogle Scholar
  18. The Lipid Research Clinics Coronary Primary Prevention Trial Results (1984) II. The relation of reduction in incidence of coronary heart disease to cholesterol. JAMA 251: 365CrossRefGoogle Scholar
  19. WHO European Collaborative Group (1983) Multifactorial trial in the prevention of coronary heart disease. 3. Incidence and mortality results. Eur Heart J 4: 141–147Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  1. 1.Royal InfirmaryGlasgowScotland, UK
  2. 2.Stobhill General HospitalGlasgowScotland, UK

Personalised recommendations